These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12665854)

  • 1. Calpain silencing by a reversible intrinsic mechanism.
    Moldoveanu T; Hosfield CM; Lim D; Jia Z; Davies PL
    Nat Struct Biol; 2003 May; 10(5):371-8. PubMed ID: 12665854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.
    Hosfield CM; Elce JS; Davies PL; Jia Z
    EMBO J; 1999 Dec; 18(24):6880-9. PubMed ID: 10601010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and structural details of Ca(2+)-induced conformational changes in the EF-hand domain VI of calpain.
    Cygler M; Grochulski P; Blanchard H
    Methods Mol Biol; 2002; 172():243-60. PubMed ID: 11833352
    [No Abstract]   [Full Text] [Related]  

  • 5. Roles of individual EF-hands in the activation of m-calpain by calcium.
    Dutt P; Arthur JS; Grochulski P; Cygler M; Elce JS
    Biochem J; 2000 May; 348 Pt 1(Pt 1):37-43. PubMed ID: 10794711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.
    Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS
    Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
    Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
    Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site.
    Moldoveanu T; Campbell RL; Cuerrier D; Davies PL
    J Mol Biol; 2004 Nov; 343(5):1313-26. PubMed ID: 15491615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation.
    Fernández-Montalván A; Assfalg-Machleidt I; Pfeiler D; Fritz H; Jochum M; Machleidt W
    Biol Chem; 2006 May; 387(5):617-27. PubMed ID: 16740134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
    Kiss R; Kovács D; Tompa P; Perczel A
    Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-mediated degradation of reversibly oxidized protein-tyrosine phosphatase 1B.
    Trümpler A; Schlott B; Herrlich P; Greer PA; Böhmer FD
    FEBS J; 2009 Oct; 276(19):5622-33. PubMed ID: 19712109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain.
    Jia Z; Petrounevitch V; Wong A; Moldoveanu T; Davies PL; Elce JS; Beckmann JS
    Biophys J; 2001 Jun; 80(6):2590-6. PubMed ID: 11371436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second binding site revealed by C-terminal truncation of calpain small subunit, a penta-EF-hand protein.
    Leinala EK; Arthur JS; Grochulski P; Davies PL; Elce JS; Jia Z
    Proteins; 2003 Nov; 53(3):649-55. PubMed ID: 14579356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calpain-system of Drosophila melanogaster: coming of age.
    Friedrich P; Tompa P; Farkas A
    Bioessays; 2004 Oct; 26(10):1088-96. PubMed ID: 15382138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide.
    Diaz BG; Moldoveanu T; Kuiper MJ; Campbell RL; Davies PL
    J Biol Chem; 2004 Jun; 279(26):27656-66. PubMed ID: 15073171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and mechanism of interleukin-1 beta converting enzyme.
    Wilson KP; Black JA; Thomson JA; Kim EE; Griffith JP; Navia MA; Murcko MA; Chambers SP; Aldape RA; Raybuck SA
    Nature; 1994 Jul; 370(6487):270-5. PubMed ID: 8035875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of human aquaporin 0 by m-calpain.
    Ma H; Azuma M; Shearer TR
    FEBS Lett; 2005 Dec; 579(30):6745-8. PubMed ID: 16310784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of calpain and insights into Ca(2+)-dependent activation.
    Jia Z; Hosfield CM; Davies PL; Elce JS
    Methods Mol Biol; 2002; 172():51-67. PubMed ID: 11833359
    [No Abstract]   [Full Text] [Related]  

  • 20. Ca2+ dependency of calpain 3 (p94) activation.
    García Díaz BE; Gauthier S; Davies PL
    Biochemistry; 2006 Mar; 45(11):3714-22. PubMed ID: 16533054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.